1. Home
  2. MCD vs NVS Comparison

MCD vs NVS Comparison

Compare MCD & NVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MCD

McDonald's Corporation

N/A

Current Price

$324.86

Market Cap

233.3B

ML Signal

N/A

Logo Novartis AG

NVS

Novartis AG

N/A

Current Price

$155.75

Market Cap

310.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MCD
NVS
Founded
1940
1895
Country
United States
Switzerland
Employees
N/A
75267
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.3B
310.4B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
MCD
NVS
Price
$324.86
$155.75
Analyst Decision
Buy
Hold
Analyst Count
28
4
Target Price
$342.21
$118.00
AVG Volume (30 Days)
3.1M
2.4M
Earning Date
05-14-2026
01-01-0001
Dividend Yield
2.27%
1.92%
EPS Growth
4.92
N/A
EPS
11.95
N/A
Revenue
$26,885,000,000.00
N/A
Revenue This Year
$8.05
$2.56
Revenue Next Year
$5.72
$4.91
P/E Ratio
$27.49
$23.13
Revenue Growth
3.72
N/A
52 Week Low
$283.47
$97.72
52 Week High
$341.75
$170.46

Technical Indicators

Market Signals
Indicator
MCD
NVS
Relative Strength Index (RSI) 46.72 42.95
Support Level $320.15 $113.19
Resistance Level $335.67 $158.80
Average True Range (ATR) 4.74 2.44
MACD -1.57 -1.63
Stochastic Oscillator 17.43 4.39

Price Performance

Historical Comparison
MCD
NVS

About MCD McDonald's Corporation

McDonald's is the world's largest restaurant brand, with nearly $131 billion in systemwide sales across more than 44,000 restaurants and over 100 markets. The quick-service chain built its early reputation on speed, consistency, and affordable hamburgers, and today its global menu spans burgers, chicken, breakfast, and beverages that have helped popularize American fast-food cuisine worldwide. The firm derives the bulk of its revenue from franchise royalties and rent (about 61%), with the remainder stemming from company-operated restaurants across three segments: the United States (41% of systemwide sales), international operated markets (34%), and international developmental/licensed markets (25%).

About NVS Novartis AG

Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, respiratory, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.

Share on Social Networks: